These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19105708)

  • 1. Cancer vaccines: will we ever learn?
    Johnson RS; Walker AI; Ward SJ
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):67-74. PubMed ID: 19105708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of dendritic cell vaccines.
    Morse MA; Lyerly HK
    Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for colorectal cancer and renal cell carcinoma.
    Kabaker K; Shell K; Kaufman HL
    Cancer J; 2011; 17(5):283-93. PubMed ID: 21952277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous renal cell cancer vaccines using heat shock protein-peptide complexes.
    Aalamian M; Fuchs E; Gupta R; Levey DL
    Urol Oncol; 2006; 24(5):425-33. PubMed ID: 16962495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell based cancer vaccines: regulatory and commercial development.
    Copier J; Ward S; Dalgleish A
    Vaccine; 2007 Sep; 25 Suppl 2():B35-46. PubMed ID: 17916462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
    Acres B
    J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.
    Hoos A; Levey DL
    Expert Rev Vaccines; 2003 Jun; 2(3):369-79. PubMed ID: 12903802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer vaccines: what we know and what we don't yet know.
    von Mehren M
    Semin Oncol; 2005 Feb; 32(1):76-84. PubMed ID: 15726509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines in renal cell carcinoma.
    Kübler H; Vieweg J
    Semin Oncol; 2006 Oct; 33(5):614-24. PubMed ID: 17045091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferons in oncology.
    Woll PJ; Pettengell R
    Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial watch : Progress for Phase III cancer vaccines.
    Nat Rev Drug Discov; 2008 Dec; 7(12):966-7. PubMed ID: 19043443
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
    Csatary LK; Moss RW; Beuth J; Töröcsik B; Szeberenyi J; Bakacs T
    Anticancer Res; 1999; 19(1B):635-8. PubMed ID: 10216468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
    Timmerman JM
    Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials referral resource. Non-small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Feb; 4(2):51-63. PubMed ID: 2167113
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic cancer vaccines: why so few randomised phase III studies reflect the initial optimism of phase II studies.
    Dalgleish AG
    Vaccine; 2011 Nov; 29(47):8501-5. PubMed ID: 21933695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine in renal cell carcinoma: are we nearing reality?
    Bedke J; Gouttefangeas C; Kruck S; Stenzl A
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1503-5. PubMed ID: 23253216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of vaccination in the adjuvant treatment of cancer of the kidney].
    Fayette J
    Bull Cancer; 2004 Mar; 91(3):211. PubMed ID: 15171044
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine therapy for renal cancer.
    Amato RJ
    Expert Rev Vaccines; 2008 Sep; 7(7):925-35. PubMed ID: 18767943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology evaluation: HSPPC-96, antigenics.
    Minev BR
    Curr Opin Mol Ther; 2003 Dec; 5(6):680-7. PubMed ID: 14755896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.